HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alex Loukas Selected Research

Persistent Infection

1/2022Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini.
1/2016Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.
11/2015The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation.
8/2015Diterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O-acetylneoline in a murine model of ulcerative colitis.
10/2012The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.
3/2011Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alex Loukas Research Topics

Disease

65Infections
01/2022 - 01/2003
34Hookworm Infections (Hookworm Infection)
01/2022 - 08/2004
26Schistosomiasis (Bilharziasis)
11/2021 - 07/2006
24Inflammation (Inflammations)
02/2024 - 08/2008
17Neoplasms (Cancer)
09/2023 - 06/2007
15Opisthorchiasis
01/2022 - 11/2008
14Colitis
01/2022 - 04/2009
12Reinfection
01/2022 - 07/2006
11Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022 - 03/2013
10Cholangiocarcinoma
01/2020 - 01/2009
6Persistent Infection
01/2022 - 03/2011
6Wounds and Injuries (Trauma)
10/2018 - 02/2002
5Fibrosis (Cirrhosis)
05/2021 - 10/2009
5Parasitic Diseases (Parasitic Disease)
01/2021 - 01/2010
5Celiac Disease (Celiac Sprue)
12/2020 - 03/2011
4Necrosis
12/2022 - 11/2011
4Schistosomiasis haematobia (Schistosomiasis haematobium)
01/2022 - 01/2020
3Hypersensitivity (Allergy)
10/2022 - 03/2014
3Body Weight (Weight, Body)
01/2022 - 01/2018
3Asthma (Bronchial Asthma)
01/2022 - 01/2006
3Malaria
01/2022 - 09/2003
3Bile Duct Neoplasms (Bile Duct Cancer)
01/2021 - 01/2012
3Neglected Diseases
04/2020 - 01/2011
3Carcinogenesis
01/2018 - 06/2007
3Echinococcosis (Hydatid Cysts)
08/2011 - 01/2006
2Rheumatoid Arthritis
04/2022 - 01/2019
2Experimental Arthritis
04/2022 - 01/2019
2Arthritis (Polyarthritis)
04/2022 - 01/2019
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2020
2Nematode Infections
12/2021 - 01/2020
2Infertility (Sterility)
09/2021 - 08/2011
2Bites and Stings (Sting)
01/2021 - 01/2012
2Weight Loss (Weight Reduction)
01/2021 - 08/2015
2Communicable Diseases (Infectious Diseases)
11/2018 - 02/2015
2Digestive System Diseases
01/2018 - 01/2017
2Cutaneous Leishmaniasis
01/2012 - 11/2011
2Cysts
08/2011 - 03/2008
2Helminthiasis (Helminthiases)
11/2010 - 01/2006

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
02/2024 - 02/2004
49VaccinesIBA
01/2022 - 01/2003
23AntigensIBA
01/2022 - 02/2005
12CytokinesIBA
09/2023 - 11/2011
12AntibodiesIBA
11/2021 - 10/2005
11TetraspaninsIBA
01/2022 - 07/2006
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2023 - 10/2009
8Subunit VaccinesIBA
01/2022 - 01/2012
8Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2012
8GranulinsIBA
01/2022 - 10/2011
8ProteomeIBA
01/2021 - 01/2016
7AnthelminticsIBA
12/2021 - 05/2006
7Praziquantel (Biltricide)FDA Link
05/2021 - 01/2008
7Glutens (Glutelin)IBA
12/2020 - 01/2011
7EnzymesIBA
04/2020 - 08/2008
6CarcinogensIBA
01/2022 - 06/2007
6Peptides (Polypeptides)IBA
01/2022 - 01/2012
6Peptide Hydrolases (Proteases)FDA Link
06/2013 - 09/2003
5Immunoglobulin G (IgG)IBA
01/2022 - 11/2008
5Immunoglobulin E (IgE)IBA
03/2014 - 02/2004
4AllergensIBA
10/2022 - 01/2006
4VenomsIBA
01/2021 - 02/2002
3MicroRNAs (MicroRNA)IBA
05/2023 - 01/2018
3Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2020
3InterleukinsIBA
12/2022 - 01/2012
3InflammasomesIBA
11/2019 - 01/2018
3Recombinant ProteinsIBA
10/2017 - 07/2006
3Mebendazole (Anti-Worm)FDA Link
01/2016 - 05/2006
3Interleukin-6 (Interleukin 6)IBA
11/2015 - 10/2009
3Synthetic Vaccines (Recombinant Vaccines)IBA
03/2009 - 10/2005
2ProgranulinsIBA
03/2023 - 01/2020
2Blood Glucose (Blood Sugar)IBA
01/2023 - 01/2020
2Protein Subunit VaccinesIBA
01/2022 - 09/2021
2NitrosaminesIBA
01/2022 - 05/2011
2EpitopesIBA
01/2022 - 01/2014
2Albendazole (Albenza)FDA Link
12/2021 - 05/2006
2Monoclonal AntibodiesIBA
07/2021 - 01/2015
2Complex MixturesIBA
01/2021 - 03/2010
2Sulfonic AcidsIBA
01/2021 - 04/2009
2Interleukin-4 (Interleukin 4)IBA
01/2020 - 06/2013
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2019 - 03/2007
2PhytochemicalsIBA
11/2018 - 08/2015
2RNA (Ribonucleic Acid)IBA
01/2018 - 03/2014
2Messenger RNA (mRNA)IBA
10/2017 - 04/2009
2Hemoglobins (Hemoglobin)IBA
01/2015 - 03/2011
2Formaldehyde (Formol)FDA Link
01/2015 - 03/2012
2ImmunosorbentsIBA
01/2015 - 03/2012
2ethyl acetateIBA
01/2015 - 03/2012
2Interleukin-22 (IL-22)IBA
03/2013 - 02/2012
2PeroxiredoxinsIBA
10/2012 - 03/2012
2Cathepsin BIBA
03/2012 - 08/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2012 - 08/2008
2AnnexinsIBA
08/2011 - 03/2010
2SaposinsIBA
01/2011 - 11/2008
2Interleukin-10 (Interleukin 10)IBA
01/2011 - 01/2006

Therapy/Procedure

14Therapeutics
04/2022 - 01/2008
6Mass Drug Administration
12/2017 - 06/2008
4Drug Therapy (Chemotherapy)
03/2014 - 01/2008
3Immunomodulation
12/2019 - 01/2017
2Traditional Medicine (Folk Remedies)
02/2024 - 08/2015
2Therapy with Helminths
01/2021 - 01/2019
2Aftercare (After-Treatment)
01/2017 - 01/2012